Dental Tribune International (12/4, Schein) reported that Henry Schein has expanded its agreement with Swiss company vVARDIS to exclusively distribute Curodont Repair Fluoride Plus across all US dental market segments starting January 1, 2026. This noninvasive treatment targets early-stage carious lesions. The agreement, which builds on a 2024 exclusivity for dental support organizations, now includes general dentistry, orthodontics, and pediatric dentistry. Stanley M. Bergman, CEO of Henry Schein, emphasized the partnership’s role in enhancing dental practice efficiency and community oral health, while vVARDIS co-founders noted their success in treating over 500,000 patients.
Link: https://www.drbicuspid.com/dental-hygiene/infection-control/article/15773073/lanmark360-the-infection-control-resource-dental-practices-should-know